Karyopharm Therapeutics (KPTI) Trading Summary
Trading Session
The last 24‑hour period ended at 06:22 AM Central Europe on Friday, 23 November 2026.
Karyopharm Therapeutics shares increased by 28.77 % during that session.
Price and Market Data
Current share price: USD 0.55.
Shares outstanding: 22.5 million.
Market capitalization: USD 9.6 million.
Volume traded in the last 24 hours: USD 4.1 million.
Historical Performance
Since the end of last month, the stock has declined by 68.8 %.
200‑day simple moving average: USD 6.26.
52‑week high: USD 10.99 (24 February 2026).
52‑week low: USD 0.31 (15 October 2026).
Recent Performance of Related Stocks
| Ticker | Recent 24‑hour change | Current price | Market cap (USD mn) |
|---|---|---|---|
| CARV | 0 % | 1.79 | 11.2 |
| LSTA | –3.81 % | 1.00 | 11.3 |
| PASG | –0.28 % | 3.51 | 11.6 |
| GTBP | +2.03 % | 5.52 | 11.2 |
| TCRT | –1.30 % | 3.04 | 11.1 |
Company Overview
Karyopharm Therapeutics Inc. is an oncology‑focused pharmaceutical company listed on Nasdaq (ticker: KPTI). The company specializes in biotechnology and develops combination therapies that pair dexamethasone with other agents for patients with pretreated multiple myeloma. It also investigates single‑agent and combination regimens for a range of human cancers. Operations cover the United States, Germany, and Israel. The company’s website is www.karyopharm.com . Karyopharm went public on 6 November 2013.
